Navigation Links
Nobel Spotlight on IVF Boosts Family Building Procedures
Date:10/13/2010

SEATTLE, Oct. 13 /PRNewswire/ -- With the Nobel prize for medicine awarded to Robert Edwards, the pioneer British biologist who developed in vitro fertilization (IVF) for humans, "any remaining doubts about the importance of 'test tube babies' that have lingered over the past 32 years ago should finally be put to rest," says Michael S. Opsahl, M.D., recently named one of "Washington State's Best Doctors" in Washington Magazine.

"IVF, once perceived as expensive and a last resort for infertile couples, is now considered a first-line infertility treatment because it works so well," said Opsahl of Northwest Center for Reproductive Sciences.

"I will never forget the birth of the first IVF baby July 25, 1978, because it was also my birthday and I had just graduated from med school. I was somewhat surprised by the paranoia that surrounded the birth," he said. "The idea of engineering super humans was far from our minds; curing infertility was foremost."

Later that year, Opsahl attended lectures by Professor Edwards and his partner, gynecologist Patrick Steptoe, now deceased. "It seemed to be almost science fiction—even for those of us in the field," he added.

"We will continue to have unresolved issues around rapidly changing scientific knowledge, especially with regard to assisted reproductive technologies, which sometimes elicit strong emotional opinions," he said. "In truth, we only proceed with thoughtful evidence-based steps. Best of all, long-term studies reassure us that IVF children are as healthy and intelligent as other children," Opsahl said.

Today, the national average for IVF success is approximately 30 percent, compared to 5 to 10 percent in the first decade of IVF. At NCRS, rates are 64 percent for women under 35; 48 percent for women 35 to 37; and 37 percent for women 38 to 40 (according to statistics collected during 2005-2009 for the Society for Assisted Reproductive Technology.)

About Northwest Center for Reproductive Sciences

With clinics in Kirkland and Seattle, NCRS is a partnership of senior physicians and scientists who have been honored with numerous accolades, such as Seattle Magazine's "Top Doctors." Senior staff members, including physicians, laboratory scientists and administrators, each possess over 20 years' experience in the reproductive medicine field. For additional information, visit http://www.nwreprosci.com.


'/>"/>
SOURCE Northwest Center for Reproductive Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Graphene pioneers follow in Nobel footsteps
2. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
3. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
4. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
5. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
6. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
7. Thomson Reuters Predicts Nobel Laureates
8. Nobelprize.org Expands Channels and News Services for the 2009 Nobel Prize Announcements
9. Argonne's Advanced Photon Source Lit the Way to Chemistry Nobel
10. BMCC Student—the Only Community College Winner—Lands Grand Prize in Nobel Science Challenge
11. Protege of Nobel Prize Winner Robert Edwards Carries on his IVF Legacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:6/9/2016)... Paris Police Prefecture ... solution to ensure the safety of people and operations in ... major tournament Teleste, an international technology group specialised ... today that its video security solution will be utilised by ... public safety across the country. The system roll-out is scheduled ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
Breaking Biology News(10 mins):